A citation-based method for searching scientific literature

Samilia Obeng-Gyasi, Cecilia Ong, E Shelley Hwang. Chin Clin Oncol 2016
Times Cited: 5







List of co-cited articles
7 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
Victor G Vogel, Joseph P Costantino, D Lawrence Wickerham, Walter M Cronin, Reena S Cecchini, James N Atkins, Therese B Bevers, Louis Fehrenbacher, Eduardo R Pajon, James L Wade,[...]. JAMA 2006
40

Lobular carcinoma in situ: A rare form of mammary cancer.
F W Foote, F W Stewart. Am J Pathol 1941
411
40

Changing incidence of lobular carcinoma in situ of the breast.
Christopher I Li, Benjamin O Anderson, Janet R Daling, Roger E Moe. Breast Cancer Res Treat 2002
66
40

Trends in incidence and management of lobular carcinoma in situ: a population-based analysis.
Pamela R Portschy, Schelomo Marmor, Rumbidzayi Nzara, Beth A Virnig, Todd M Tuttle. Ann Surg Oncol 2013
31
40

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
B Fisher, J P Costantino, D L Wickerham, C K Redmond, M Kavanah, W M Cronin, V Vogel, A Robidoux, N Dimitrov, J Atkins,[...]. J Natl Cancer Inst 1998
40

Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk.
Tari A King, Melissa Pilewskie, Shirin Muhsen, Sujata Patil, Starr K Mautner, Anna Park, Sabine Oskar, Elena Guerini-Rocco, Camilla Boafo, Jessica C Gooch,[...]. J Clin Oncol 2015
83
40



Appropriate margin for lumpectomy excision of invasive breast cancer.
Andrea V Barrio, Monica Morrow. Chin Clin Oncol 2016
7
20


Ultrasound image-guided core biopsy of the breast.
V Suzanne Klimberg, Amy Rivere. Chin Clin Oncol 2016
5
20

Alternatives to whole breast irradiation in early breast cancer.
V Suzanne Klimberg, Amy Rivere, Loverd Peacock. Chin Clin Oncol 2016
1
100

Cancer statistics in China, 2015.
Wanqing Chen, Rongshou Zheng, Peter D Baade, Siwei Zhang, Hongmei Zeng, Freddie Bray, Ahmedin Jemal, Xue Qin Yu, Jie He. CA Cancer J Clin 2016
20

The way to precision medicine of our team.
Fengrui Xu, Xiaodi Wang, Zefei Jiang. Chin Clin Oncol 2016
1
100




Chemotherapy principles of managing stage IV breast cancer in the United States.
Leonel F Hernandez-Aya, Cynthia X Ma. Chin Clin Oncol 2016
9
20

Advances in the surgical treatment of breast cancer.
Lei Xing, Qiang He, Yuan-Yuan Wang, Hong-Yuan Li, Guo-Sheng Ren. Chin Clin Oncol 2016
10
20



Organizing a breast cancer database: data management.
Min Yi, Kelly K Hunt. Chin Clin Oncol 2016
1
100

Training of breast surgical oncologists.
Mediget Teshome, Henry M Kuerer. Chin Clin Oncol 2016
3
33

Breast-conserving therapy versus modified radical mastectomy: socioeconomic status determines who receives what--results from case-control study in Tianjin, China.
Jing-Jing Liu, Sheng Zhang, Xiaomeng Hao, Juan Xie, Jing Zhao, Jing Wang, Lin Liu, Peizhong Peter Wang, Jin Zhang. Cancer Epidemiol 2012
22
20


Racial disparities in risk of second breast tumors after ductal carcinoma in situ.
Ying Liu, Graham A Colditz, Sarah Gehlert, Melody Goodman. Breast Cancer Res Treat 2014
13
20

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Lisa A Carey, Charles M Perou, Chad A Livasy, Lynn G Dressler, David Cowan, Kathleen Conway, Gamze Karaca, Melissa A Troester, Chiu Kit Tse, Sharon Edmiston,[...]. JAMA 2006
20

Second primary breast cancer occurrence according to hormone receptor status.
Allison W Kurian, Laura A McClure, Esther M John, Pamela L Horn-Ross, James M Ford, Christina A Clarke. J Natl Cancer Inst 2009
80
20

Second cancers following in situ carcinoma of the breast.
S Franceschi, F Levi, C La Vecchia, L Randimbison, V C Te. Int J Cancer 1998
31
20

High Ki67 expression is a risk marker of invasive relapse for classical lobular carcinoma in situ patients.
Anne Vincent-Salomon, David Hajage, Alexandre Rouquette, Aurélie Cédenot, Nadège Gruel, Séverine Alran, Xavier Sastre-Garau, Brigitte Sigal-Zafrani, Alain Fourquet, Youlia Kirova. Breast 2012
10
20

Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast.
Yunn-Yi Chen, Eun-Sil Shelley Hwang, Ritu Roy, Sandy DeVries, Joseph Anderson, Chrystal Wa, Patrick L Fitzgibbons, Timothy W Jacobs, Gaetan MacGrogan, Hans Peterse,[...]. Am J Surg Pathol 2009
82
20

Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer.
P O Chappuis, V Nethercot, W D Foulkes. Semin Surg Oncol 2000
108
20




BRCA1 regulates human mammary stem/progenitor cell fate.
Suling Liu, Christophe Ginestier, Emmanuelle Charafe-Jauffret, Hailey Foco, Celina G Kleer, Sofia D Merajver, Gabriela Dontu, Max S Wicha. Proc Natl Acad Sci U S A 2008
323
20


Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases.
Bruno Cutuli, Brigitte De Lafontan, Youlia Kirova, Hugues Auvray, Agnes Tallet, Sandrine Avigdor, Claire Brunaud, Catherine Delva. Radiat Oncol 2015
14
20

BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50.
Robert W Haile, Duncan C Thomas, Valerie McGuire, Anna Felberg, Esther M John, Roger L Milne, John L Hopper, Mark A Jenkins, A Joan Levine, Mary M Daly,[...]. Cancer Epidemiol Biomarkers Prev 2006
68
20

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version).
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, D Craig Allred, Karen L Hagerty, Sunil Badve, Patrick L Fitzgibbons, Glenn Francis, Neil S Goldstein, Malcolm Hayes,[...]. Arch Pathol Lab Med 2010
654
20

Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.
Paul J Chuba, Merlin R Hamre, Johnny Yap, Richard K Severson, David Lucas, Falah Shamsa, Amr Aref. J Clin Oncol 2005
142
20

Is steroid receptor profile in contralateral breast cancer a marker of independence of the corresponding primary tumour?
D Coradini, S Oriana, L Mariani, R Miceli, G Bresciani, E Marubini, G Di Fronzo. Eur J Cancer 1998
47
20

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.
Sunil R Lakhani, Marc J Van De Vijver, Jocelyne Jacquemier, Thomas J Anderson, Peter P Osin, Lesley McGuffog, Douglas F Easton. J Clin Oncol 2002
586
20

Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer.
Sandra M Swain, John W Wilson, Eleftherios P Mamounas, John Bryant, D Lawrence Wickerham, Bernard Fisher, Soon Paik, Norman Wolmark. J Natl Cancer Inst 2004
73
20

Atypical hyperplastic lesions of the female breast. A long-term follow-up study.
D L Page, W D Dupont, L W Rogers, M S Rados. Cancer 1985
731
20

Biomarker profile and genetic abnormalities in lobular carcinoma in situ.
Syed K Mohsin, Peter O'Connell, D Craig Allred, Arlene L Libby. Breast Cancer Res Treat 2005
31
20

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.
Jack Cuzick, Ivana Sestak, John F Forbes, Mitch Dowsett, Jill Knox, Simon Cawthorn, Christobel Saunders, Nicola Roche, Robert E Mansel, Gunter von Minckwitz,[...]. Lancet 2014
340
20

Lobular neoplasia (so-called lobular carcinoma in situ) of the breast.
C D Haagensen, N Lane, R Lattes, C Bodian. Cancer 1978
387
20

Lobular carcinoma in situ of the breast.
R A Goldschmidt, T A Victor. Semin Surg Oncol 1996
20
20

Lobular carcinoma in situ: observation without surgery as an appropriate therapy.
W Carson, E Sanchez-Forgach, P Stomper, R Penetrante, T N Tsangaris, S B Edge. Ann Surg Oncol 1994
37
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.